Gene test could predict antidepressant success
NCT ID NCT00308893
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a specific gene (BDNF) influences how well people with major depression respond to antidepressants. Researchers compared the gene variations in 188 patients who either improved or did not improve after 3 to 6 weeks of treatment. The goal is to better understand why some people don't respond to standard antidepressants and potentially guide more personalized treatment in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CPU CHRU de Tours
Tours, 37044, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Can a structured care pathway ease teen depression?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can a nasal spray break through tough depression?